Skip to main content

IP Group — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

126
Companies
$1.2B
Total invested
$11.2M
Avg. check
58
Industries
Biotechnology 9Health Care 7Software 6Medical 4Therapeutics 4Manufacturing 3+52 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 126
Additive Assurance
December 2022

Additive Assurance offers quality assurance for metal additive manufacturing.

Industrial Engineering · Melbourne$4.1M Venture - Series Unknown
Carisma Therapeutics
September 2022

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

Biotechnology · Philadelphia$30.0M Series C
Kale United
September 2022

Kale United invests in vegan startups.

Angel Investment · Stockholm$3.0M Equity Crowdfunding
Innervace
September 2022

Innvervace develops regenerative therapy solutions for neurodegenerative disorders.

Biotechnology · Philadelphia$40.0M Series A
Somalytics
August 2022

Somalytics commercializes miniature sensors for eye tracking, human-machine interface, wearables, and industrial safety.

Electronics · Seattle$1.9M Seed
Gripable
August 2022

Gripable develops digital therapy tools, combining them with mobile games, and motivating physically impaired patients.

Health Care · London$946K Grant
Spirea
June 2022

Spirea Ltd. operates as a healthcare technology company.

Biotechnology · Cambridge$2.9M Venture - Series Unknown
Cambridge Raman Imaging
May 2022

Cambridge Raman Imaging is developing a microscope which uses graphene to modulate ultra-short pulses of light to diagnose cancer tumours.

Health Diagnostics · Petersfield$1.4M Seed
Kynos Therapeutics
April 2022

Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.

Biotechnology · Edinburgh$8.5M Seed
Helio Display Materials
March 2022

Helio Display Materials offers foundational materials for the new wave of display innovation driven by color conversion.

Electronics · Oxford$4.8M Series A
WaveOptics
January 2022

WaveOptics designs Augmented Reality (AR) wearables with enhanced features.

Augmented Reality · AbingdonVenture - Series Unknown
8power
January 2022

8power is a University of Cambridge start-up developing novel technology for sensing and measurement in industrial applications.

Industrial Automation · CambridgePrivate Equity
SAM Labs
January 2022

SAM Labs is an edtech company that empowers teachers with the most engaging STEAM solution.

Education · LondonPrivate Equity
CareAlign
November 2021

CareAlign provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care.

Developer Tools · Philadelphia$2.3M Seed
Ultraleap
November 2021

Ultraleap is working to create the most remarkable connection between people and technology.

Augmented Reality · Bristol$80.9M Series D
Talivest
November 2021

Talivest is a people analytics SaaS company, specialising in employee engagement through innovative technology solutions.

Analytics · Dublin$1.0M Seed
Jetra Therapeutics
October 2021

Jetra Therapeutics develops new treatment for obesity-related liver disease designed to reduce stress in liver cells.

Biotechnology · Brisbane$1.3M Seed
Monolith AI
August 2021

Monolith AI develops an AI assistant designed to help engineers improve product development.

Analytics · London$9.6M Series A
Arkivum
August 2021

Arkivum is a leading digital archiving and preservation SaaS provider.

Cloud Data Services · Reading$2.2M Private Equity
Mobilion Systems
July 2021

MOBILion Systems specializes in identifying and analyzing challenging molecules that other instruments so far have failed to detect.

Analytics · Chadds Ford$60.0M Series C
MITEK Medical Materials
November 2025

MITEK Medical Materials focuses on the research and development and supply of medical-grade bioactive/bioenergy medical materials.

Xian$7.0M Seed
RAGE Biotech
November 2025

RAGE Biotech is a biotechnology industry.

Biotechnology · Melbourne$18.9M Series A
Amprologix
October 2025

Amprologix Ltd is a world-leading biotechnology and synthetic biology company Ingenza.

Biotechnology · Plymouth$992K Seed
MISSION Therapeutics
October 2025

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

Biotechnology · Cambridge$13.3M Series Unknown

Where IP Group invests

Biotechnology9
Health Care7
Software6
Medical4
Therapeutics4
Manufacturing3

About IP Group's portfolio

How many companies has IP Group invested in?▸

IP Group has invested in 126 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does IP Group invest in?▸

IP Group's top investment sectors include Biotechnology, Health Care, Software, Medical, Therapeutics. The firm invests across 58 different industry categories.

What is IP Group's largest investment?▸

Among tracked funding rounds, Ultraleap received $80.9M in a Series D round. IP Group's total known invested capital is $1.2B.

What is the average investment size for IP Group?▸

IP Group's average investment size is $11.2M across its portfolio of 126 companies.

What are IP Group's most recent investments?▸

Recent IP Group portfolio additions include Additive Assurance, Carisma Therapeutics, Kale United, Innervace, Somalytics. These companies were founded in 2020 or later.

Reach the founders behind these 126 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →